Clinical trial
A Multi-center, Open-Label Study to Evaluate the Efficacy and Safety of Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease
NCT04870372 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Soochow University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Open-Label Study to Evaluate the Efficacy and Safety of Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease
- Lead sponsor
- Second Affiliated Hospital of Soochow University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 1, 2020
- Completion date
- April 30, 2021
- Enrollment
- 141 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.